Table 4 Main clinical characteristics of patients group according to ApoA1 and CRP levels
Variables | ApoA1(g/L) | Â | CRP | Â |
|---|---|---|---|---|
Median (Range) | p-Value | Median(Range) | p-Value | |
Gender | ||||
 Male | 1.10(0.15–1.80) | 0.236 | 3.685(0.16–251.70) | 0.083 |
 Female | 1.09(0.56–1.72) |  | 2.60(0.10–92.96) |  |
Age (years) | ||||
  < 53 | 1.095(0.23–1.80) | 0.539 | 4.08(0.16–210.65) | 0.064 |
  ≥ 53 | 1.10(0.15–1.72) |  | 2.89(0.10–251.70) |  |
TNM stage | ||||
 I-II | 1.13(0.15–1.80) | < 0.001 | 2.255(0.10–241.15) | < 0.001 |
 III-IV | 1.03(0.16–1.64) |  | 9.61(0.24–251.70) |  |
Tumor size(cm) | ||||
  < 5 | 1.13(0.15–1.80) | < 0.001 | 2.35(0.10–241.25) | < 0.001 |
  ≥ 5 | 1.03(0.16–1.64) |  | 9.66(0.24–251.70) |  |
Tumor number | ||||
 Single | 1.10(0.15–1.80) | 0.544 | 2.73(0.10–251.70) | 0.001 |
 Multiple | 1.10(0.41–1.64) |  | 5.60(0.24–132.49) |  |
Node stage | ||||
 N0 | 1.10(0.15–1.80) | 0.059 | 3.425(0.10–251.70) | 0.005 |
 N1–2 | 1.01(0.35–1.48) |  | 8.03(0.57–194.10) |  |
Distant metastases | ||||
 No | 1.10(0.15–1.80) | 0.169 | 3.49(0.10–251.70) | 0.008 |
 Yes | 1.04(0.16–1.56) |  | 9.66(0.60–92.96) |  |
BMI (kg/m2) | ||||
  ≥ 24.0 | 1.085(0.30–1.72) | 0.756 | 2.89(0.16–241.25) | 0.264 |
 18.5–23.9 | 1.11(0.15–1.80) |  | 4.03(0.10–251.70) |  |
  < 18.5 | 1.08(0.41–1.77) |  | 4.75(0.25–146.40) |  |
Alcohol behavior | ||||
 Never | 1.10(0.15–1.80) | 0.802 | 3.59(0.10–194.10) | 0.409 |
 Previous/Current | 1.08(0.16–1.65) |  | 3.56(0.16–251.70) |  |
Family history of cancer | ||||
 No | 1.10(0.15–1.80) | 0.772 | 3.56(0.10–251.70) | 0.403 |
 Yes | 1.10(0.16–1.77) |  | 3.765(0.30–126.24) |  |
HBs Ag | ||||
 Negative | 1.10(0.15–1.80) | 0.664 | 3.28(0.23–251.70) | 0.780 |
 Positive | 1.10(0.15–1.80) |  | 3.56(0.10–210.65) |  |
HBe Ag | ||||
 Negative | 1.07(0.15–1.80) | 0.492 | 3.71(0.16–251.70) | 0.754 |
 Positive | 1.12(0.16–1.52) |  | 3.79(0.25–130.04) |  |
HCV Ab | ||||
 Negative | 1.10(0.15–1.80) | 0.197 | 3.64(0.10–251.70) | 0.075 |
 Positive | 1.02(0.26–1.64) |  | 1.88(0.23–194.10) |  |
AFP (ng/mL) | ||||
  < 400 | 1.11(0.16–1.80) | 0.020 | 3.10(0.10–251.70) | < 0.001 |
  ≥ 400 | 1.04(0.15–1.58) |  | 8.20(0.30–241.25) |  |